← Scroll for more →
Perspective Therapeutics, Inc. (CATX)
Pharmaceutical Preparations
Latest Price
$0.87
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.84
P/B Ratio
0.31
Institutional Ownership
73.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.49M | $32.0M | 8.32% | +4.15M | 2026-06-30 |
| TCG Crossover Management, LLC | 7.92M | $26.0M | 6.94% | -- | 2026-06-30 |
| Commodore Capital LP | 6.34M | $21.0M | 5.55% | -- | 2026-06-30 |
| Avidity Partners Management LP | 6.30M | $21.0M | 5.52% | +250.0K | 2026-06-30 |
| State Street Corp | 6.05M | $20.0M | 5.30% | +2.92M | 2026-06-30 |
| Millennium Management LLC | 4.91M | $16.0M | 4.31% | +865.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.44M | $15.0M | 3.89% | +57.6K | 2026-06-30 |
| Citadel Advisors LLC | 3.81M | $12.0M | 3.34% | +165.5K | 2026-06-30 |
| Spruce Street Capital LP | 3.69M | $12.0M | 3.24% | +1.07M | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.32M | $11.0M | 2.91% | +325.8K | 2026-06-30 |